Barrier Therapeutics to Present At the Cowen and Company 28th Annual Health Care Conference
March 10, 2008 16:30 ET
|
Barrier Therapeutics, Inc.
BOSTON, March 10, 2008 (PRIME NEWSWIRE) -- Barrier Therapeutics, Inc. (Nasdaq:BTRX), a pharmaceutical company that develops and markets dermatology products, today announced that executive management...
Barrier Therapeutics to Present At Susquehanna's SIGnificant Investment Options in Healthcare Conference
February 26, 2008 07:30 ET
|
Barrier Therapeutics, Inc.
PRINCETON, N.J., Feb. 26, 2008 (PRIME NEWSWIRE) -- Barrier Therapeutics, Inc. (Nasdaq:BTRX), a pharmaceutical company that develops and markets dermatology products, today announced that executive...
Barrier Therapeutics to Release Fourth Quarter and Full Year 2007 Financial Results On February 28, 2008
February 21, 2008 07:30 ET
|
Barrier Therapeutics, Inc.
PRINCETON, N.J., Feb. 21, 2008 (PRIME NEWSWIRE) -- Barrier Therapeutics, Inc. (Nasdaq:BTRX), a pharmaceutical company developing and commercializing products in the field of dermatology, will release...
Barrier Therapeutics to Present At ROTH 20th Annual OC Growth Stock Conference
February 13, 2008 07:00 ET
|
Barrier Therapeutics, Inc.
PRINCETON, N.J., Feb. 13, 2008 (PRIME NEWSWIRE) -- Barrier Therapeutics, Inc. (Nasdaq:BTRX), a pharmaceutical company that develops and markets dermatology products, today announced that executive...
Barrier Therapeutics to Present Scientific Posters At the American Academy of Dermatology 66th Annual Meeting
February 01, 2008 08:00 ET
|
Barrier Therapeutics, Inc.
PRINCETON, N.J., Feb. 1, 2008 (PRIME NEWSWIRE) -- Barrier Therapeutics, Inc. (Nasdaq:BTRX), a pharmaceutical company that develops and markets dermatology products, today announced that it will...
Barrier Therapeutics Announces Top Management Succession Plan
January 25, 2008 17:58 ET
|
Barrier Therapeutics, Inc.
PRINCETON, N.J., Jan. 25, 2008 (PRIME NEWSWIRE) -- Barrier Therapeutics, Inc. (Nasdaq:BTRX) announced today that, in line with its strategy to continue the aggressive commercialization of its internal...
Barrier Therapeutics to Present At the 26th Annual JPMorgan Healthcare Conference
January 02, 2008 11:38 ET
|
Barrier Therapeutics, Inc.
PRINCETON, N.J., Jan. 2, 2008 (PRIME NEWSWIRE) -- Barrier Therapeutics, Inc. (Nasdaq:BTRX), a pharmaceutical company that develops and markets dermatology products, today announced that executive...
Barrier Therapeutics to Present At the RBC Capital Markets Healthcare Conference On December 13, 2007
December 06, 2007 07:30 ET
|
Barrier Therapeutics, Inc.
PRINCETON, N.J., Dec. 6, 2007 (PRIME NEWSWIRE) -- Barrier Therapeutics, Inc. (Nasdaq:BTRX), a pharmaceutical company developing and commercializing products in the field of dermatology, today...
Barrier Therapeutics Announces Positive Results of Dose Escalation Clinical Safety Study With Pramiconazole
November 27, 2007 07:00 ET
|
Barrier Therapeutics, Inc.
PRINCETON, N.J., Nov. 27, 2007 (PRIME NEWSWIRE) -- Barrier Therapeutics, Inc. (Nasdaq:BTRX), a pharmaceutical company that develops and markets dermatology products, today announced positive results...
Barrier Therapeutics to Present At the Acumen BioFin Rodman & Renshaw Healthcare Conference On November 6, 2007
October 29, 2007 07:30 ET
|
Barrier Therapeutics, Inc.
PRINCETON, N.J., Oct. 29, 2007 (PRIME NEWSWIRE) -- Barrier Therapeutics, Inc. (Nasdaq:BTRX), a pharmaceutical company developing and commercializing products in the field of dermatology, today...